24СʱÈÈÃÅ°æ¿éÅÅÐаñ    

²é¿´: 1822  |  »Ø¸´: 3
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

Miumiu°®Ð¡Óã

гæ (СÓÐÃûÆø)

[½»Á÷] °ÄÃÅ´óѧ³ÂнÌÊÚ¿ÎÌâ×é2018ÄêÕÐÊÕ˶ʿÑо¿Éú£¬²©Ê¿Ñо¿Éú, Ñо¿ÖúÀí¼°²©Ê¿ºóÑо¿Ô±

°ÄÃÅ´óѧ³ÂнÌÊÚ (Professor Xin CHEN) ¿ÎÌâ×é2018ÄêÕÐÊÕ˶ʿÑо¿Éú£¬²©Ê¿Ñо¿Éú, ²©Ê¿ºóÑо¿Ô±

ÒªÇó£º ¾ßÓÐÉúÎï¡¢Ò½Ò©Ïà¹Øѧ¿Æѧ룬ÊìϤ¶¯ÎïʵÑ鼰ϸ°û²Ù×÷¼¼Êõ£¬¾ßÓÐÃâÒßѧ±³¾°ÓÅÏÈ¡£¶Ô¿ÆѧÑо¿ÓÐÇ¿ÁÒÐËȤ£¬ÎªÈ˳ÏÐÅ£¬¹¤×÷ÇÚ·Ü£¬ÉÆÓÚ¹µÍ¨£¬ÓжÀÁ¢Ë¼¿¼¼°¹¤×÷ÄÜÁ¦£¬²©Ê¿ºó¼°²©Ê¿ÉúÉêÇëÕßÐèÓз¢±íSCIÎÄÕ¾­Ñ飬ӢÎÄˮƽÐèÒª·ûºÏ°ÄÃÅ´óѧҪÇó¡£
Ñо¿·½Ïò£º ÃâÒßµ÷½Ú»úÖƼ°ÃâÒßÒ©Àí
н³ê£º×ñÑ­°ÄÃÅÕþ¸®¼°°ÄÃÅ´óѧµÄÓйع涨¡£
ÁªÏµ·½Ê½£º »¶Ó­Ö±½ÓÁªÏµ³ÂнÌÊÚ(Professor Xin CHEN)£¨xchen@umac.mo£©¡£
ÉêÇ뷽ʽ£º ÍøÉϱ¨Ãû£¬¾ßÌ屨Ãû¼°ÕÐÉúÒªÇóÇë²ÎÔÄ°ÄÃÅ´óѧÑо¿ÉúÔºÍøÒ³£¨http://www.umac.mo/grs/cn/admissions.php£©

Selective recent publications (* corresponding or co-corresponding author):

1. Yingjie Nie, Jiang He, Hidekazu Shirota, Anna L. Trivett, De Yang, Dennis M. Klinman, Joost J. Oppenheim, Xin Chen*. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Science Signaling 2018. Jan 2. 11(511): pii: eaan0790. pii: eaan0790. doi: 10.1126/scisignal.aan0790

2. Shuoyang Liu and Xin Chen*. Dietary Therapy May Be Sufficient for Type 1 Diabetes Treatment. Cellular and Molecular Immunology. 2018 Feb;15(2):85-87. doi: 10.1038/cmi.2017.56.

3. Ping Li, Ying Zheng and Xin Chen*. Drugs for Autoimmune Inflammatory Diseases: from Small Molecule Compounds to anti-TNF Biologics. Frontiers in Pharmacology. 2017 Jul 12;8:460. doi: 10.3389/fphar.2017.00460.

4. Xin Chen* and J.J. Oppenheim, Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer. Science Signaling 2017. 10(462). pii: eaal2328. doi: 10.1126/scisignal.aal2328

5. Yingjie Nie, De Yang, Anna Trivett, Haiyun Xin, Zhen Han, Xin Chen, Joost J. Oppenheim. Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Big Solid Tumors. Scientific Reports 2017 Oct 27;7(1):14186. doi: 10.1038/s41598-017-14655-8.

6. Xin Chen*, and Joost J Oppenheim. Paradoxical effects of anti-TNF treatment of autoimmunity. Nature Reviews Rheumatology. 2016. 2016 Nov;12(11):625-626. doi: 10.1038/nrrheum.2016.145.

7. B Zaragoza, Xin Chen, JJ Oppenheim, D Chader, M Miyara and BL Salomon. Suppressive activity of human Treg cells is maintained in the presence of TNF. Nature Medicine. 2016 Jan 22:16-17. doi: 10.1038/nm.4019.

8. Fan Yan, Ruijuan Du, Feng Wei, Hua Zhao, Jingpu Yu, Changli Wang, Zhongli Zhan, TingTing Ding, Xiubao Ren, Xin Chen*, Hui Li. Expression of TNFR2 by regulatory T cells in the peripheral blood is correlated to the clinicopathology of lung cancer patients. Cancer Immunology, Immunotherapy. 2015 Nov;64(11):1475-85.

9. Ryoko Hamano, Xueqiang Wu, Yitao Wang, Joost J Oppenheim and Xin Chen*. Characterization of MT-2 cells as a human regulatory T cell-like cell line. Cellular & Molecular Immunology. 2015 Nov;12(6):780-2.

10. Xin Chen*, Jami Willette-Brown, Xueqiang Wu, Ya Hu, O.M. Zack Howard, Yinling Hu and Joost J Oppenheim. IKK¦Á is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells. FASEB J. 2015, Feb;29(2):443-54.

PIѧÊõ±³¾°£¬Çë²Î¼û£º http://www.umac.mo/sklqrcm/academic_staff/xchen_ch.html
°ÄÃÅ´óѧÐÂУÇø£¬Çë²Î¼û£º http://www.umac.mo/co/gallery.php#ad-image-0
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍƼö: (ÎÒÒ²ÒªÔÚÕâÀïÍƹã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Jason__Hoo

гæ (³õÈëÎÄ̳)

ÃÀ¹úÄÏ¿¨ÂÞÀ´ÄÉ´óѧ£¨University of South Carolina£©Î»ÓÚÃÀ¹ú¶«Äϲ¿ÄÏ¿¨ÂÞÀ´ÄÉÖÝ£¬´´Á¢ÓÚ1801Ä꣬ÊÇÃÀ¹úÀúÊ·×îÓƾõĹ«Á¢´óѧ֮һ¡£ÄÏ¿¨ÂÞÀ´ÄÉ´óѧ£¨ÄÏ¿¨´óѧ£©±»ÃÀ¹úÐÂÎÅÓëÊÀ½ç±¨µÀÔÚ2008ÄêÓþΪÔÚÃÀ¹úÇ°10´ó×î¾ß´´ÐºÍǰ;µÄ´óѧ¡£ÏÖÎÒУ¼ÆËã»ú¿ÆѧÓ빤³Ìϵ½ô¼±ÌØÕÐ2018Çï¼¾²©Ê¿Ñо¿Éú10-20Ãû.


½±Ñ§½ð£º¼¸ºõËùÓеIJ©Ê¿ÉúºÍһЩ˶ʿÉú¶¼ÄÜ»ñµÃÖúÑлòÕßÖú½Ì×ÊÖú£¬²©Ê¿ÉúTA/RA£¬Ã¿ÔµĽòÌù·¶Î§´Ó1500ÃÀÔªµ½2200ÃÀÔª£¬È¡¾öÓÚ·ÖÅäµÄÖ°Ôð»òËûÃÇËù´ÓʵÄÏîÄ¿¡£ÖúÑÐÖú½ÌºÍFellowshipÒ²°üÀ¨Ñ§·Ñ¡£ÎÒϵÿÄêÌṩ½ü200ÍòÃÀÔªµÄÑо¿Éú×ÊÖú¡£Ñ§Ð£ËùÔÚ³ÇÊÐColumbiaÏû·ÑµÍÁ®£¬ËùÓлñµÃ×ÊÖúµÄ²©Ê¿Éú¶¼ÎÞÐèΪÉú»î¿ªÖ§·¢³î£¬¿ÉרÐÄÓÚѧϰ¿ÆÑС£


ÕÐÊÕרҵ·½Ïò£º ÎÒϵÔÚ¹ýÈ¥13ÄêÖÐÒÑ»ñµÃ13´ÎÃÀ¹ú¹ú¼Ò¿Æѧ»ù½ð»á½Ü³öÇàÄê»ù½ð½±£¨NSF Career Awards£©¡£²©Ê¿ÉúÕÐÊÕ·½Ïò°üÀ¨È˹¤ÖÇÄÜ£¬¼ÆËã»úÊÓ¾õ£¬ÍøÂ簲ȫ£¬»úÆ÷ѧϰ¡¢Éî¶ÈѧϰºÍ´óÊý¾Ý·ÖÎö£¬ÉúÎïÐÅϢѧºÍ»ùÒò×éѧ£¬²ÄÁÏÐÅϢѧ£¬Òƶ¯¼ÆË㣬»úÆ÷ÈËѧ£¬Èí¼þ¹¤³ÌºÍÎÞÏßÍøÂçµÈÁìÓò¡£ÏêÇéÇë²Î¿¼

¾Íҵǰ¾°£º µ±Ç°ÃÀ¹úITÒµ·¢Õ¹Ñ¸ËÙ£¬ÎÒϵ²©Ê¿±ÏÒµÉú100% ¾ÍÒµÂÊ¡£¾ø´ó¶àÊý¶¼³É¹¦½øÈëÈ«Çò×¼â¹«Ë¾°üÀ¨±ÈÈçGoogle£¬Facebook£¬ÑÇÂíÑ·£¬ LinkedIn£¬Indeed£¬VisaºÍ΢Èí¡£Äêн´Ó10-20ÍòÃÀÔª£¨Ô¼65Íò-130ÍòÈËÃñ±Ò£©²»µÈ¡£


ÉêÇëÌõ¼þ£º»ñµÃ¹úÄÚ¼ÆËã»ú»òÏà¹Øרҵ£¨µç×Ó¡¢»úе¡¢Í¨ÐÅ¡¢¿ØÖÆ¡¢Êýѧ¡¢Í³¼ÆµÈ£©±¾¿Æ»ò˶ʿѧ룬³É¼¨ÓÅÐã¡£Ph.D. program, GRE Quantitative scores of 165 or higher, and GRE Verbal of 150 or higher. TOEFL score of 80 or higher, or an IELTS score of 6.5 or higher. ±¾¿Æ˶ʿ·Ç¼ÆËã»úºÍÏà¹ØרҵµÄͬѧҲ»¶Ó­ÉêÇ룬ÎÒϵ֧³Ö¿çѧ¿ÆµÄ¿ÆѧÑо¿£¬»¶Ó­¸÷רҵµÄͬѧ×Éѯ¡£


ÉêÇëÁ÷³Ì£º ×¼±¸ÉêÇë²ÄÁÏ£¨GRE/TOEFL or IELTS³É¼¨£¬ ³É¼¨µ¥£¬2·âÍƼöÐÅ£¬¼òÀú£¬£©Ìá½»ÄãµÄUSCÑо¿ÉúÔºÉêÇë±í£¬ÉêÇëרҵ·½ÏòÎÊÌâ¿ÉÁªÏµÎÒϵÏà¹Ø½ÌÊÚ¡£Ç¿ÁÒ½¨Ò黹ûÓлñµÃofferµÄͬѧÌá½»ÉêÇë¡£



ÉêÇëÂÌɫͨµÀ£ºÎÒÃǶÔѧҵ³É¼¨ÌرðÓÅÐãµÄÉêÇëÕߣ¨²»ÏÞÓÚ¼ÆËã»úרҵ£©ÌṩÒÔÏÂÉêÇë°ïÖú£º1£©¼õÃâÉêÇë·Ñ£» 2£©½öÐèÌṩGRE/TOEFL³É¼¨µÄɨÃ踴ӡ¼þ£¨Õýʽ¼þ¿ÉÔÚ¼ȡºó²¹Æ룩3£©Ìṩµç»°»ò΢ÐÅÃæÊÔ»ñµÃÌáÇ°ÍƼö¼ȡ»ú»á;3)¶Ô¼ÆËã»úѧҵÓÅÐ㵫GRE/TOEFL³É¼¨ÓÐǷȱµÄѧÉúÌṩÆƸñ¼ȡ»ú»á¡£ÂÌɫͨµÀµÄÉêÇëÕßÇëºÍÎÒϵÑо¿ÉúÕÐÉú°ìÖ÷ÈκúÀÏʦֱ½ÓÁªÏµ£¨jianjunh #cse dot sc dot edu£©



»¹ÓÐÆäËûÎÊÌ⣿ ÇëºÍÎÒϵÑо¿ÉúÕÐÉú°ìÖ÷ÈκúÀÏʦÁªÏµ or ͨ¹ýÓëÎÒÃÇÁªÏµ
4Â¥2018-02-19 22:46:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

Miumiu°®Ð¡Óã

гæ (СÓÐÃûÆø)

2Â¥2018-02-19 18:38:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[»ù½ðÉêÇë] ÈëÖ°¸ßУ3Äê·¢±í10+SCI£¬¾¡ÈËÊÂÌýÌìÃü +3 kaoyan250 2024-05-27 3/150 2024-05-27 23:31 by lyfbangong
[»ù½ðÉêÇë] ¹¤²Ä01ËÍÁËÂ𣿠+6 xiaopang8958 2024-05-25 10/500 2024-05-27 22:45 by andyrenp
[¿¼²©] 24»ò25É격 +4 Jacob- 2024-05-22 7/350 2024-05-27 21:21 by °²ËþÍßÀ­¶à
[¿¼²©] ÕÐƸ´ß»¯¡¢´¢Äܲ©Ê¿ +4 dfjsf 2024-05-24 8/400 2024-05-27 21:08 by ÈýÃÉȦȦ
[Óлú½»Á÷] »úÀíÇóÖú 200+3 15147165026 2024-05-26 6/300 2024-05-27 20:31 by ARENASARENAS
[»ù½ðÉêÇë] »ù½ðÉÏ»á +13 mrKiller 2024-05-25 18/900 2024-05-27 19:51 by °¢Ä®ÏÈÉú
[»ù½ðÉêÇë] ºÓ±±Ê¡»ù½ð 50+3 ÏþÏþ°®´ä´ä 2024-05-23 22/1100 2024-05-27 19:41 by ÏþÏþ°®´ä´ä
[»ù½ðÉêÇë] ÃæÉÏ»ù½ð»áÆÀר¼Ò£¬ÓлرܻúÖÆÂ𣿠+4 huang1991js 2024-05-27 4/200 2024-05-27 19:08 by ÐÇ»ð12
[µç»¯Ñ§] ÈçºÎÖ¤Ã÷µç¼«É϶ÆÉϽðÁË£¿ 10+4 ¿Ìӡʱ¹â 2024-05-22 8/400 2024-05-27 19:00 by ÕÅÇá³¾
[¿¼²©] 25²©Ê¿ÉêÇë +5 1872075 2024-05-25 7/350 2024-05-27 18:52 by FERGUSKB
[¿¼²©] 24Ä격ʿÕÐÉú +3 abinit432 2024-05-27 4/200 2024-05-27 17:49 by ¼ñÁ˸öÎ÷¹Ï
[»ù½ðÉêÇë] ¿ÆÑÐÖ®ÓÑÔĶÁÁ¿½üÒ»ÖÜÔö¼ÓÁË200¶à¡£ +13 hdzw9071 2024-05-24 14/700 2024-05-27 17:29 by leeeru
[½Ìʦ֮¼Ò] Çཷ×öʵÑéÂð +3 €Ðì·ïÄê 2024-05-22 3/150 2024-05-27 16:25 by otani
[²ÄÁÏ×ÛºÏ] ÇóÖú£¬¸ÕÈëÃÅMOFºÏ³É£¬ÊµÑé×ÜÊÇʧ°Ü 20+3 ÕÅÔ°ë 2024-05-25 7/350 2024-05-27 08:48 by mkpooooo
[»ù½ðÉêÇë] ת·¢£¬¡±ÅóÓÑ˵Õкô¶¼¶¨µã´òµ½ËûÄÇÀïÁË£¢ +25 babu2015 2024-05-23 30/1500 2024-05-27 05:38 by wangzhenyft
[˶²©¼ÒÔ°] ÎĿƲ©ÔÚľ³æÉÏ´æÔڸкõÍѽ +6 hahamyid 2024-05-25 9/450 2024-05-27 00:09 by Æ®¹ýµÄÍí±²
[˶²©¼ÒÔ°] ÑÐ0 +6 ¿ØÖƵ÷¼Áyl 2024-05-25 11/550 2024-05-26 23:37 by sakuraai
[ÂÛÎÄͶ¸å] ÕæÊÇÆæ¹ÖµÄ±à¼­²¿£¿ +5 jjdg 2024-05-23 5/250 2024-05-25 21:57 by cqu_zzh
[»ù½ðÉêÇë] Ìý˵ÃæÇàµØE09ÒѾ­ËÍÁËô£¿ +6 ²æÉÕ³Ô²æÉÕ 2024-05-21 9/450 2024-05-23 12:24 by ²æÉÕ³Ô²æÉÕ
[»ù½ðÉêÇë] ¹ú×ÔÈ»µÈ 80+4 ÅÖ»¢ 2024-05-21 12/600 2024-05-22 09:47 by nono2009
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û